EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 40 / No 1 (January-March 2005) Radioprotection, 40 1 (2005) 57-71 References
Free Access
Issue
Radioprotection
Volume 40, Number 1, January-March 2005
Page(s) 57 - 71
DOI https://doi.org/10.1051/radiopro:2004016
Published online 16 March 2005
  • Bonet-Maury P., Patti F. (1950) L’irradiation mortelle de la souris par les rayons X et γ. Essais thérapeutiques, J. Radiol. Electrol. Arch. Electr. Méd. 31, 286-290. [Google Scholar]
  • Célariès B., Court L., Lion C., Rima G., Roman V. (2001a) Organometallic compounds of silicon and germanium in chemical radioprotection, Main Group Met. Chem. 25, 58. [Google Scholar]
  • Célariès B., Rima G., Court L., Lion C., Roman V., Laval J.D. (2001b) Radioprotective activity and synthesis of siladithioacetals and germadithioacetals derived from N-substituted naphthylethylimidazoline, Metal-Based Drugs 8, 199-210. [CrossRef] [PubMed] [Google Scholar]
  • Célariès B., Amourette C., Lion C., Rima G. (2003a) Radioprotective activity of metalladithioacetals derived from N-substituted naphthylethylimidazoline, Appl. Organomet. Chem. 17, 135-138. [CrossRef] [Google Scholar]
  • Célariès B., Amourette C., Lion C., Rima G. (2003b) Synthesis and radioprotective study of new siladithioacetals and germadithioacetals, Appl. Organomet. Chem. 17, 561-569. [CrossRef] [Google Scholar]
  • Davidson D.E., Grenan M.M., Sweeney T.R. (1980) Radiation Sensitizers. Their use in the clinical management of cancer (Luther W. Brady, Ed.) p. 309. Masson pub., USA. [Google Scholar]
  • Fatôme M., Sentenac-Roumanou H., Lion C., Satgé J., Fourtinon M., Rima G. (1984) Radioprotective effect of germanium dithioacetals of cysteamine and methylcysteamine, Eur. J. Med. Chem. 19, 119-122. [Google Scholar]
  • Fatôme M., Sentenac-Roumanou H., Lion C., Satgé J., Rima G. (1988) Study of germathiazolidines and germylated dithioacetals derived from N-substituted cysteamine and methylcysteamine: synthesis and radioprotective activity, Eur. J. Med. Chem. 23, 257-266. [CrossRef] [Google Scholar]
  • Finney D.J. (1971) Probit. Analysis: a statistical treatment of the sigmoid response curve, 3rd edn. Cambridge University Press. [Google Scholar]
  • Laval J.D., Roman V., Laduranty J., Miginiac L., Lion C., Sentenac-Roumanou H., Fatôme M. (1993) Radioprotective effect of low doses of 2-(1-naphthylmethyl)-2-imidazoline alone or associated with phosphorothioates, Eur. J. Med. Chem. 28, 709-713. [CrossRef] [Google Scholar]
  • Piper J.R., Stringfellow C.R., Elliot R.D., Johnston T.P. (1969a) S-2-(omega-aminoalkylamino)ethyl dihydrogen phosphorothioates and related compounds as potential antiradiation agents, J. Med. Chem. 12, 236-243. [CrossRef] [PubMed] [Google Scholar]
  • Piper J.R., Stringfellow C.R., Johnston T.P. (1969b) Terminally substituted S-2-(omega-aminoalkylamino)ethyl dihydrogen phosphorothioates and related compounds as potential antiradiation agents, J. Med. Chem. 12, 244-253. [CrossRef] [PubMed] [Google Scholar]
  • Porta C., Maiolo A., Tua A., Grignani G. (2000) Amifostine, a reactive oxygen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF, Haematologica. 85, 820-825. [PubMed] [Google Scholar]
  • Rima G., Satgé J., Fatôme M., Laval J.D., Sentenac-Roumanou H., Lion C., Lazraq M. (1991) Syntheses and radioprotective activities of trithiagermatranes, trithiasilatranes, germylated oxide and sulfide with cysteamine and N-(2-thioethyl)-1,3-diaminopropane hydrochloride ligands, Eur. J. Med. Chem. 26, 291-297. [CrossRef] [Google Scholar]
  • Rima G., Satgé J., Sentenac-Roumanou H., Fatôme M., Lion C., Laval J.D. (1993) New organogermylated compounds N-substituted by naphthylmethylimidazoline hydrochloride, and imidazoline: synthesis and radioprotective activity, Eur. J. Med. Chem. 28, 761-767. [CrossRef] [Google Scholar]
  • Rima G., Satgé J., Sentenac-Roumanou H., Fatôme M., Laval J.D., Lion C., Alazard O., Chabertier P. (1994) Synthesis and radiopharmacological study of new metalated thiazolidines and dithioacetals of N-allyl-substituted cysteamine and methylcysteamine, Appl. Organomet. Chem. 8, 481-490. [CrossRef] [Google Scholar]
  • Rima G., Satgé J., Sentenac-Roumanou H., Fatôme M., Laval J.D., Lion C., Dagiral R. (1996) New germaheterocycles, germadithioacetals and a germylated oxide and sulfide derived from cysteamine, methylcysteamine and N-substituted cysteamine: synthesis and radioprotective activity, Appl. Organomet. Chem. 10, 113-123. [CrossRef] [Google Scholar]
  • Rima G., Satgé J., Sentenac-Roumanou H., Fatôme M., Laval J.D., Lion C., Thiriot C., Dagiral R., Martin C. (1997) Synthesis and radioprotective properties of new metallathiazolidines, dialkyloxathiagermolanes, dialkylgermocanes and metalladithioacetals, Main Group Met. Chem. 20, 255-267. [CrossRef] [Google Scholar]
  • Rima G., Satgé J., Dagiral R., Lion C., Fatôme M., Roman V., Laval J.D. (1998) Synthesis and radioprotective activity of new organosilicon and germanium compounds, Metal-Based Drugs 5, 139-146. [CrossRef] [PubMed] [Google Scholar]
  • Rima G., Satgé J., Dagiral R., Lion C., Fatôme M., Roman V., Laval J.D. (1999a) Synthesis and application of new organometallic compounds of silicon and germanium in chemical radioprotection, Appl. Organomet. Chem. 13, 583-594. [CrossRef] [Google Scholar]
  • Rima G., Satgé J., Dagiral R., Lion C., Sentenac-Roumanou H., Fatôme M., Roman V., Laval J.D. (1999b) A review on the radioprotective activity of organogermanium and organosilicon compounds, Metal-Based Drugs 6, 49-60. [CrossRef] [PubMed] [Google Scholar]
  • Satgé J., Cazes A., Bouchaut M., Fatôme M., Sentenac-Roumanou H., Lion C. (1982) Synthesis and radioprotective activity of germa- and silathiazolidines, Eur. J. Med.Chem. 17, 433-436. [Google Scholar]
  • Satgé J., Rima G., Fatôme M., Sentenac-Roumanou H., Lion C. (1989) Syntheses and radioprotective activities of germatranes, silatranes, germylated oxides and sulfides with cysteamine, methylcysteamine and N-(2-thioethyl)-1,3-diaminopropane hydrochloride ligands, Eur. J. Med. Chem. 24, 48-54. [CrossRef] [Google Scholar]
  • Washburn L.C., Carlton J.E., Hayes R.L., Yuhas J.M. (1974) Distribution of WR 2721 in normal and malignant tissues of mice and rats bearing solid tumors. Dependence on tumor type, drug dose, and species, Radiat. Res. 59, 475-483. [CrossRef] [PubMed] [Google Scholar]
  • Washburn L.C., Rafter J.J., Hayes R.L., Yuhas J.M. (1976) Prediction of the effective radioprotective dose of WR-2721 in humans through an interspecies tissue distribution study, Radiat. Res. 66, 100-105. [CrossRef] [PubMed] [Google Scholar]
  • Yuhas J.M. (1970) Biological factors affecting the radioprotective efficiency of S-2-[2-aminopropylamino] ethylphosphorothioic acid (WR-2721). LD50/30j doses, Radiat. Res. 44, 621-628. [CrossRef] [PubMed] [Google Scholar]
  • Yuhas J.M. (1972) Improvement of lung tumor radiotherapy through differential chemoprotection of normal and tumor tissue, J. Natl-Cancer Inst. 48, 1255-1257. [Google Scholar]
  • Yuhas J.M. (1973) Radiotherapy of experimental lung tumors in the presence and absence of a radioprotective drug, S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), J. Natl-Cancer Inst. 50, 69-78. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.